Cardinal Health, Inc. $CAH Shares Sold by Stack Financial Management Inc

Key Points

• Stack Financial Management Inc reduced its stake in Cardinal Health, Inc. by 1.6%, now holding 104,507 shares valued at approximately $17.56 million.
• Cardinal Health's recent quarterly earnings showed an EPS of $2.08, exceeding expectations, while its revenue slightly increased by 0.5% year-over-year.
• The company declared a quarterly dividend of $0.5107 per share, with a dividend yield of 1.3%, set to be paid on October 15th.

Stack Financial Management Inc cut its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 104,507 shares of the company's stock after selling 1,727 shares during the quarter. Cardinal Health accounts for 1.6% of Stack Financial Management Inc's portfolio, making the stock its 26th largest position. Stack Financial Management Inc's holdings in Cardinal Health were worth $17,557,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Wellington Management Group LLP grew its holdings in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI grew its holdings in shares of Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock worth $130,434,000 after acquiring an additional 927,950 shares during the last quarter. Nuveen LLC acquired a new position in shares of Cardinal Health in the 1st quarter worth $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new position in shares of Cardinal Health in the 1st quarter worth $104,951,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.2%

Shares of Cardinal Health stock opened at $156.86 on Monday. The stock has a 50-day moving average price of $152.09 and a 200 day moving average price of $151.31. The company has a market cap of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of recent research reports. Leerink Partners lifted their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an "outperform" rating in a report on Monday, October 6th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Argus set a $189.00 price target on Cardinal Health in a report on Friday, August 22nd. Finally, UBS Group reissued a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average price target of $166.00.

Insider Activity at Cardinal Health

In other news, CEO Stephen M. Mason sold 41,575 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares of the company's stock, valued at $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.